Abstract
The year 2020 brought significant challenges to all of us in our professional and personal lives, as we have had to face the ravages and disruptions of the COVID-19 pandemic. Despite these challenges, Maternal-Fetal Medicine had a very productive year thanks to our authors, reviewers, leadership, and members of the journal's Editorial Board. Many papers were well received by our readers and cited in subsequent publications in top scientific journals, including The Lancet Infection Diseases, International Federation of Gynecology and Obstetrics (a FIGO position paper), as well as high-impact journals in the field of maternal-fetal medicine. Maternal-Fetal Medicine has also been listed in the Directory of Open Access Journals (DOAJ). We recognize that 2021 will bring with its own challenges. The Editors and editorial team at Maternal-Fetal Medicine are prepared for whatever 2021 has to offer. We hereby affirm that we will continue to work tirelessly to better serve you, our authors, and our readership. Together, we can have a positive impact by providing the most up to date information in a timely and easily digestible format and sharing the insights of our experts. We will continue to promote collaborative research in China and around the world. Finally, we wish you, your families, and all of our authors and readers a peaceful and successful New Year.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
